Login to Your Account

Imperial Innovations Regaining Thiakis Obesity Drug from Pfizer

By Nuala Moran
Staff Writer

Wednesday, April 25, 2012
LONDON – Pfizer Inc. is scrapping development of OAP-189, an obesity drug originally discovered by UK company Thiakis Ltd., and said it intends to divest the program, with implications for the future milestones due to Imperial Innovations Group plc, the former majority owner of Thiakis.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription